Resina is extracted from Daemonorops draco Blume, a plant that grows in the tropical rainforests of Indonesia. Resina extract is highly sought after in Asia, especially in Hong Kong and China. In China, Resina has high medicinal value and is used as an active ingredient in TCM products. TCM products which contain Resina, are used to:
Treat body sprains and act as an analgesic
Treat blood stasis and help in blood circulation
Stop bleeding and alleviating pain caused by external injuries
Promote tissue regeneration and healing wounds such as cuts, ulcers and sores
Reduce pain from blood stasis, in particular due to traumatic injuries such as those resulting from falls and fractures
SCU is currently sourcing, producing, marketing and selling Resina, commonly known as Dragon’s Blood Resin (血竭xue jie) to TCM distributors and TCM manufacturing companies in Hong Kong and China.
The Company currently procures Daemonorops draco Blume raw materials from five regular agricultural wholesalers in Indonesia, who aggregate Daemonorops draco Blume raw materials from farmers.
Resina extract products have to achieve the specifications listed below before it can be sold in China. This is a requirement by the China Pharmacopoeia Commission (中国药典委员会) of the China Food and Drugs Administration (国家食品药品监督管理总局). To ensure that SCU’s Resina extract meets the required specifications, it is rigorously inspected and authenticated by the General Administration of Quality Supervision, Inspection and Quarantine (中华人民共和国国家质量监督检验检疫总局) a ministerial administrative organ under the State Council of the People’s Republic of China.
SCU is a pioneer in the use of fingerprint mapping technologies such as High Performance Liquid Chromatography (HPLC) to identify and determine the authenticity of the Daemonorops draco Blume raw materials, test for active constituents, and ensure its potency.
China’s Specifications for Daemonorops draco Blume
|Alcohol Insoluble Matter||< 25%|
(Source: China Phamacopoeia v.2010 中国药典 2010 年版)
Resina Extraction Process